售后服務After-sale Service

Kangda Healthcare focuses on products and services in the field of in vitro diagnosis. With independent research and development technology as the core, the company has established marketing networks and sales service systems in major provinces and cities across the country based on the leading product production technology process and finished product manufacturing capacity.

In order to truly realize the customer service concept of "urgent needs, rapid response, and high-quality service", Kangda Medical has established a rapid response after-sales service team based on Beijing, Zhejiang, and Chongqing, and its service scope covers North China, East China, Southwest China and other major business regions

技術支持Technical Support

Kangda Medical is committed to the R&D, production, sales and technical services of products in the field of in vitro diagnosis. After years of accumulation, Kangda Medical has established a research and development team with superb technology and innovation, enabling the company to bring forth new ideas and surpass itself. At present, the company's R&D personnel account for more than 40% of the total number of the company.

Kangda Technology Research Institute, established in 2009, is the "Hangzhou High tech Research and Development Center". The research institute has four centers, namely FAS R&D Center, IHC R&D Center, BR R&D Center and Reference System Department. On the basis of strengthening its own R&D strength, the company has actively carried out technical exchanges and talent introduction, comprehensively accelerated the R&D and technical reserve of advanced medical equipment, and laid a solid foundation for the sustainable development of the company.

After years of technical accumulation, the company has obtained a number of industry-leading technical achievements, including 14 invention patents, 42 utility model patents, 3 software copyrights and 122 medical device registration certificates, including fecal analysis series, immunohistochemistry, biochemical reagents and other products, and another 20 invention patents and 8 utility models are under review.

Download Center
9691精品人妻无码久久久_亚洲精品97久久中文字幕无码_在线观看视频一区二区_国产精品 久久久精品软件